Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
62 auth.
F. Rivellese,
Anna E. A. Surace,
K. Goldmann,
E. Sciacca,
C. Çubuk,
G. Giorli,
C. John,
A. Nerviani,
L. Fossati-Jimack,
G. Thorborn,
Manzoor Ahmed,
E. Prediletto,
S. Church,
Briana M. Hudson,
S. Warren,
...
P. McKeigue,
F. Humby,
M. Bombardieri,
Michael R. Barnes,
Costantino Pitzalis,
F. Rivellese,
A. Nerviani,
L. Fossati-Jimack,
F. Humby,
P. Durez,
M. Buch,
H. Rizvi,
A. Mahto,
C. Montecucco,
B. Lauwerys,
N. Ng,
P. Ho,
V. Romão,
João Eurico Cabral da Fonseca,
P. Verschueren,
S. Kelly,
P. Sainaghi,
N. Gendi,
B. Dasgupta,
A. Cauli,
P. Reynolds,
J. Cañete,
J. Ramírez,
R. Celis,
R. Moots,
P. Taylor,
C. Edwards,
J. Isaacs,
P. Sasieni,
E. Choy,
C. Thompson,
S. Bugatti,
M. Bellan,
M. Congia,
C. Holroyd,
A. Pratt,
L. White,
Louise Warren,
Joanna Peel,
R. Hands,
G. Hadfield,
Costantino Pitzalis
|
|
7 |
2022 |
Social Media Posts